Herpes Zoster Vaccine Can Save Your Patients' Eyesight Herpes Zoster Vaccine Can Save Your Patients' Eyesight
Herpes zoster ophthalmicus can be devastating. Dr Rapuano urges all ophthalmologists to discuss the zoster vaccine with their patients.Medscape Ophthalmology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 21, 2022 Category: Consumer Health News Tags: Ophthalmology Viewpoint Source Type: news

Recommendations Updated for Recombinant Zoster Vaccine
THURSDAY, Jan. 20, 2022 -- Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged 19 years and older; the recommendations are... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 20, 2022 Category: Pharmaceuticals Source Type: news

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes the ACIP recommendations for two doses of RZV to prevent herpes zoster and related complications in immunocompromised adults. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - January 20, 2022 Category: American Health Tags: Adult Health Adult Vaccinations Advisory Committee on Immunization Practices (ACIP) MMWR Morbidity & Mortality Weekly Report Shingles (Herpes Zoster) Shingles Vaccination Source Type: news

Pfizer and BioNTech sign new global collaboration agreement to develop first mRNA-based shingles vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a new research, development and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles (herpes zoster virus, or HZV), a debilitating, disfiguring and painful disease that impacts about one in three people in the United States during their lifetime. (Source: World Pharma News)
Source: World Pharma News - January 6, 2022 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Pfizer and BioNTech team up to develop mRNA-based shingles vaccine
Drugmakers set to take on GSK as they aim to replicate Covid jab success (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - January 5, 2022 Category: Pharmaceuticals Source Type: news

Flu/Shingles Shot Combo May Hurt Future Flu Vaccine Uptake Flu/Shingles Shot Combo May Hurt Future Flu Vaccine Uptake
The year after people receive concurrent flu and shingles shots, flu shots dip, which could mean that people are incorrectly associating adverse effects with the flu vaccine, researchers suggest.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - November 22, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

Some confuse symptoms of the shingles vaccine for flu shot if received on same day
Researchers from Harvard Medical School found that people who receive their shingles and flu vaccines together are less likely to return and get their flu shot again in subsequent years. (Source: the Mail online | Health)
Source: the Mail online | Health - November 19, 2021 Category: Consumer Health News Source Type: news

Janssen Reports Positive Topline Week 48 Phase 2 Results for TREMFYA ® (guselkumab) in Adults With Moderately to Severely Active Crohn's Disease
SPRING HOUSE, PENNSYLVANIA, November 17, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced topline results from the Phase 2 GALAXI 1 clinical trial which showed rates of clinical remission (Crohn’s Disease Activity Index [CDAI]
Source: Johnson and Johnson - November 17, 2021 Category: Pharmaceuticals Source Type: news

Wonderjabs! How vaccines for shingles and flu could beat stroke and even dementia, too
Mounting evidence suggests certain jabs given every year in the UK may also reduce the risk of seemingly unrelated illnesses, from ear infections to strokes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 8, 2021 Category: Consumer Health News Source Type: news

Study: Shingrix shingles vaccine riskier for Guillain-Barr é than older shot
Older adults who receive the Shingrix shingles vaccines are more than twice as likely to develop Guillain-Barr é syndrome compared with those given the older Zostavax product, a JAMA Internal Medicine study found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 1, 2021 Category: Consumer Health News Source Type: news

GSK raises profit forecasts in boost for under-fire Walmsley
Rebound in sales of shingles vaccine helps UK drugmaker beat expectations in third quarter (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 27, 2021 Category: Pharmaceuticals Source Type: news

ACIP Expands Shingrix Recs; Updates Pneumococcal Vax Guidance ACIP Expands Shingrix Recs; Updates Pneumococcal Vax Guidance
The committee voted to recommend that immunocompromised adults aged 19+ be vaccinated against shingles, and that adults with certain risk factors or aged 65 and older receive a pneumococcal vaccine.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - October 22, 2021 Category: Internal Medicine Tags: Infectious Diseases News Source Type: news

Janssen Submits Application Seeking U.S. FDA Approval of STELARA ® (ustekinumab) for the Treatment of Pediatric Patients With Juvenile Psoriatic Arthritis
HORSHAM, PENNSYLVANIA, October 8, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking expanded approval of STELARA® (ustekinumab) to treat pediatric patients ages 5 years and older with juvenile psoriatic arthritis (jPsA).The filing is supported by extrapolation of data from nine studies across both adult trials in active PsA and adult and pediatric studies in moderate to severe plaque psoriasis, totaling 3,997 patients evaluated across these closely associa...
Source: Johnson and Johnson - October 8, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Shingles vaccine could be a game-changer for arthritis and other disorders - major study
NEW RESEARCH has found a vaccine containing live shingles, or varicella-zoster, is a safe and effective treatment for people living with inflammatory disorders, who are at a higher risk of developing shingles. (Source: Daily Express - Health)
Source: Daily Express - Health - September 28, 2021 Category: Consumer Health News Source Type: news

Adults need to take seriously vaccines for other diseases besides covid-19 and flu
Thousands of them get sick annually from illnesses — such as pertussis, shingles, human papillomavirus and pneumonia — that could have been prevented by vaccination. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - September 6, 2021 Category: Consumer Health News Authors: Marlene Cimons Source Type: news

GPs to roll out non-live shingles vaccine for immunocompromised patients
GPs will be able to offer a two-dose non-live shingles vaccine to immunocompromised patients from 1 September, NHS officials have confirmed. (Source: GP Online News)
Source: GP Online News - August 19, 2021 Category: Primary Care Tags: Clinical News Source Type: news

CDC: Advisory Committee on Immunization Practices (ACIP)
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) is hosting a virtual meeting on September 29-30, 2021. The agenda will include discussions on cholera vaccine, hepatitis vaccines, herpes zoster vaccines, orthopoxvirus vaccine, pneumococcal vaccine, and tickborne encephalitis vaccine. Includes information on how to submit public comments or request permission to make a public comment during the meeting. Registration is not required and the meeting is open to the public, available online via a live webcast. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 26, 2021 Category: Rural Health Source Type: news

Shingrix Approved in the US for Prevention of Shingles in Immunocompromised Adults
Philadelphia, London -- 26 July 2021 -- GlaxoSmithKline plc today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes zoster) in adults aged... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 26, 2021 Category: Drugs & Pharmacology Source Type: news

Herpes zoster (shingles) immunisation programme 2020 to 2021: evaluation reports, PHE (updated 5th July 2021)
This report evaluates the seventh year of the shingles vaccination programme which offers the shingles vaccine to those turning 70 and 78 years old respectively. Adults remain eligible until their 80th birthday. 5 July 2021 Updated main report. 21 June 2021 Updated report to correct an error in data from one GP IT supplier. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 6, 2021 Category: Consumer Health News Source Type: news

People Are Reporting Unexpected Side Effects After COVID-19 Vaccination —But That’s Actually Normal
Abigail, a 29-year-old from New York City who asked to use a pseudonym to preserve her privacy, knew to expect some side effects after she got her second Pfizer-BioNTech COVID-19 vaccine in February. The fever, body aches and fatigue she felt were nothing surprising. But when she began experiencing heavy, “stupidly painful, debilitating” menstrual periods, she felt blindsided. “I had not heard a single person talking about it,” she says. While scientists have not confirmed that COVID-19 vaccines can cause menstrual changes like Abigail’s, she feels confident the shot was her trigger, since she...
Source: TIME: Health - April 22, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 Source Type: news

Covid vaccine and shingles: What are the symptoms of shingles? What causes it?
THE Covid vaccine has provided the sole option of exiting the pandemic and living restriction-free but has racked up a string of unfounded side-effect claims, among them shingles. What are the symptoms of shingles, and what causes it? (Source: Daily Express - Health)
Source: Daily Express - Health - April 22, 2021 Category: Consumer Health News Source Type: news

Covid: Six with autoimmune conditions developed shingles after Pfizer vaccine
A new study from Israel found that 1.2% of patients with autoimmune inflammatory rheumatic diseases developed shingles after receiving the Pfizer-BioNTech coronavirus vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - April 20, 2021 Category: Consumer Health News Source Type: news

COVID toes, Moderna arm, all-body rash: Vaccines can cause skin reactions but aren't dangerous, study says
A new study finds some COVID-19 vaccine skin reactions, including a measles-like rash and shingles, are rare, and thankfully brief, side effects. (Source: Reuters: Health)
Source: Reuters: Health - April 7, 2021 Category: Consumer Health News Source Type: news

What to Know About the Shingles Vaccine
What do you know about the shingles vaccine? Find out what it does and why it’s important for older adults to get vaccinated. (Source: WebMD Health)
Source: WebMD Health - March 23, 2021 Category: Consumer Health News Source Type: news

How Long Does the Shingles Vaccine Last
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - March 4, 2021 Category: General Medicine Source Type: news

U.S. Will Have Enough COVID-19 Vaccines for All Adults by End of May, Biden Says
(WASHINGTON) — President Joe Biden said Tuesday that the U.S. expects to take delivery of enough coronavirus vaccines for all adult Americans by the end of May, two months earlier than anticipated, as his administration announced that drugmaker Merck & Co. will help produce rival Johnson & Johnson’s newly approved shot. With the bolstered supply, Biden also announced he would be using the powers of the federal government to direct all states to prioritize vaccinating teachers, and said the federal government would provide the doses directly through its pharmacy program. He challenged states to administe...
Source: TIME: Health - March 2, 2021 Category: Consumer Health News Authors: ZEKE MILLER, LINDA A. JOHNSON and JONATHAN LEMIRE/AP Tags: Uncategorized COVID-19 wire Source Type: news

Experts Debunk COVID-19 Vaccine –Shingles Link Experts Debunk COVID-19 Vaccine –Shingles Link
Infectious disease specialists, however, disagree that this is cause and effect, but interest in the possible connection remains high.WebMD Health News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - February 10, 2021 Category: Primary Care Tags: Infectious Diseases News Source Type: news

Experts Debunk COVID-19 Vaccine-Shingles Link
Cases of shingles appearing are not surprising during the pandemic, but there's no evidence they are linked to the COVID-19 vaccine. (Source: WebMD Health)
Source: WebMD Health - February 9, 2021 Category: Consumer Health News Source Type: news

Vaccination in pregnancy (VIP), PHE (updated 31st December 2020)
This guidance contains advice for health professionals on pregnant women who are vaccinated against coronavirus (COVID-19), chicken pox (varicella), shingles or measles, mumps, rubella. Recent updates: 31st December 2020 - updated Vaccination in pregnancy (VIP) notification form. 18th December 2020 - updated VIP notification form and added COVID-19 vaccine information. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 4, 2021 Category: Consumer Health News Source Type: news

Don ’t Let the Pandemic Stop Your Shots
Even as older adults await the coronavirus vaccine, many are skipping the standard ones. That ’s not wise, health experts say. (Source: NYT Health)
Source: NYT Health - December 28, 2020 Category: Consumer Health News Authors: Paula Span Tags: your-feed-science Whooping Cough Shingles (Disease) Diphtheria Coronavirus (2019-nCoV) Influenza Elderly Epidemics Drugs (Pharmaceuticals) Pneumonia your-feed-healthcare Vaccination and Immunization Hepatitis Tetanus Minorities Source Type: news

Cost-effective or not? New research on national vaccination programs
(University of Gothenburg) Immunizing children against chickenpox would save money, but offering shingles vaccinations to all 65-year-olds would not. These are examples of findings in a University of Gothenburg thesis exploring the cost-effectiveness of Sweden's national vaccination programs. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 23, 2020 Category: Infectious Diseases Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Administration and Leadership - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Latest News - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS: Journal of Emergency Medical Services News - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Operations - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Special Topics - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Health Officials Track Safety as COVID-19 Vaccines Roll Out
By LAURAN NEERGAARD AP Medical Writer As COVID-19 vaccinations roll out to more and more people, health authorities are keeping close watch for any unexpected side effects. On Tuesday, a health worker in Alaska suffered a severe allergic reaction after receiving the Pfizer COVID-19 vaccine. She is in the hospital for another night under observation while another worker, vaccinated Wednesday, has recovered. Doctors already knew to be on the lookout after Britain reported two similar cases last week. Related: Emergency Considerations in COVID-19 Vaccine Administration In the U.S., vaccine recipients are supposed ...
Source: JEMS Patient Care - December 17, 2020 Category: Emergency Medicine Authors: JEMS Staff Tags: AP News Coronavirus Source Type: news

Moderna Says Its COVID-19 Vaccine Is 94.5% Effective In Early Tests
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p12").init({"mcp":"cbs","width":"100%","height":"100%","video":"4873156","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p12","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","job...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Covid-19 Boston, MA Featured Healthcare Status Syndicated CBSN Boston Coronavirus Coronavirus Vaccine Moderna Moderna Therapeutics Source Type: news

Early Data Suggests Moderna ’s COVID-19 Vaccine Is Nearly 95% Effective—And You Can Keep It in the Fridge
For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S. Dr. Stephen Hoge, Moderna’s presid...
Source: TIME: Health - November 16, 2020 Category: Consumer Health News Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 News News Desk wire Source Type: news

Early Data Suggests Moderna ’s COVID-19 Vaccine Is Nearly 95% Effective—And You Can Keep It in the Fridge
For the second time this month, there’s promising news from a COVID-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the U.S. and around the world. Moderna said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S. Dr. Stephen Hoge, Moderna’s presid...
Source: TIME: Science - November 16, 2020 Category: Science Authors: LAURAN NEERGAARD / AP Tags: Uncategorized COVID-19 News News Desk wire Source Type: news

One Dose Of Coronavirus Vaccine Likely Won ’ t Be Enough; ‘ We ’ re Looking At Double Shots ’
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4683970","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 31, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN Coronavirus Coronavirus Vaccine Source Type: news

About One Third of Older Americans Receive Shingles Vaccine About One Third of Older Americans Receive Shingles Vaccine
A new CDC report looks at the proportion of people 60 and older who report shingles vaccination, as well as how rates vary in regard to sex, ethnicity, and other factors.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - July 13, 2020 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

One Third of Older People Get Shingles Vaccine
About One Third of Older Americans Receive Shingles Vaccine (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 13, 2020 Category: General Medicine Source Type: news

2008 to 2018 Saw Increase in Shingles Vaccination in Over 60s
THURSDAY, July 9, 2020 -- From 2008 to 2018, there was an increase in shingles vaccination among adults aged 60 years and older, with demographic, socioeconomic, and geographic variations in vaccination rates, according to a July data brief... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 9, 2020 Category: Pharmaceuticals Source Type: news

Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib Live Herpes Zoster Vaccine Fails to Provide Long-Term Protection in RA Patients on Tofacitinib
The live herpes zoster vaccine does not provide reliable long-term protection in rheumatoid arthritis (RA) patients taking tofacitinib, a recent study suggests.Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 20, 2020 Category: Allergy & Immunology Tags: Rheumatology News Source Type: news

Shingles Vaccine Linked to Lower Stroke Risk Shingles Vaccine Linked to Lower Stroke Risk
New evidence suggests the Zoster Vaccine Live — administered to prevent shingles — could also reduce the risk of stroke in older adults.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - February 17, 2020 Category: Allergy & Immunology Tags: Neurology & Neurosurgery News Source Type: news

Shingles Vaccine Bonus: Reduced Risk of Stroke?
Title: Shingles Vaccine Bonus: Reduced Risk of Stroke?Category: Health NewsCreated: 2/12/2020 12:00:00 AMLast Editorial Review: 2/13/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 13, 2020 Category: Cardiology Source Type: news

Shingles Vaccine Bonus: Reduced Risk of Stroke?
Overall stroke risk dropped 20% among patients under age 80 who got the shingles vaccine. In patients 80 and older, risk was cut by about 10%, said researchers. (Source: WebMD Health)
Source: WebMD Health - February 12, 2020 Category: Consumer Health News Source Type: news

Uptake of shingles vaccination is more likely if proactively offered in primary care
The shingles vaccination programme is intended for people aged between 70 and 80 years, but uptake in this group has been low. This survey found that people were more likely to have had the vaccine if it was proactively offered by a GP or nurse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - February 12, 2020 Category: Consumer Health News Source Type: news

Shingles Vaccine Bonus: Reduced Risk of Stroke?
WEDNESDAY, Feb. 12, 2020 -- Seniors who get the shingles vaccine may gain stroke protection as well, a new study suggests. Shingles is a viral infection tied to heightened risk of stroke. But overall stroke risk dropped 20% among patients under age... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 12, 2020 Category: General Medicine Source Type: news